ALPA — Alpa Laboratories Balance Sheet
0.000.00%
- IN₹2.18bn
- IN₹1.04bn
- IN₹1.12bn
- 33
- 51
- 55
- 43
Annual balance sheet for Alpa Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 578 | 765 | 844 | 947 | 1,139 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 360 | 388 | 507 | 511 | 507 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,211 | 1,389 | 1,491 | 1,610 | 1,912 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 87.3 | 92.2 | 69.6 | 114 | 206 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,404 | 1,552 | 1,673 | 1,824 | 2,226 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 325 | 314 | 296 | 281 | 467 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 327 | 335 | 327 | 305 | 512 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,076 | 1,217 | 1,346 | 1,519 | 1,714 |
Total Liabilities & Shareholders' Equity | 1,404 | 1,552 | 1,673 | 1,824 | 2,226 |
Total Common Shares Outstanding |